Literature DB >> 6331647

Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture.

S L Fitzpatrick, M P LaChance, G S Schultz.   

Abstract

Epidermal growth factor (EGF) may play a role in regulating growth of breast cancer cells in vivo. We have examined the action of EGF on breast cancer cells in vitro and characterized the EGF receptor as a model system for its action in vivo. All of the fourteen breast cancer cell lines which grow attached to culture dishes specifically bound EGF, including one purportedly normal breast line (HBL-100). The one cell line examined which grows as a suspension, DU-4475, did not express measurable levels of EGF binding. The number of EGF binding sites per cell for the different cell lines varied from 200 EGF binding sites/cell (for MDA-MB-436) to 700,000 EGF binding sites/cell (for MDA-MB-231), with most cell lines having approximately 10,000 EGF binding sites/cell. Scatchard analysis of EGF binding to four of the breast cell lines indicated a single class of high-affinity binding sites for MDA-MB-231 cells (Kd = 200 pM; n = 220 fmol of EGF bound/mg of cell protein); and for T-47D cells (Kd = 4 nM, n = 85 fmol of EGF bound/mg of cell protein) and curvilinear plots for MCF-7 cells and HBL-100 cells. The EGF binding to MDA-MB-231 cells was specific for EGF and was maximum after 2 hr at 37 degrees, followed by a progressive loss of cell-associated radio-activity, which was prevented by the action of the lysosomal inhibitory agent chloroquine. Specific covalent binding of 125I-EGF to MDA-MB-231 cells indicated that the EGF receptor had molecular weights of 165,000 and 140,000. MCF-7 cells and T-47D cells grown in serum-free medium supplemented with 10 nM EGF for 3 days had significantly increased protein, DNA, and cell number, whereas MDA-MB-231 and ZR-75-1 cells did not respond significantly to EGF. These results indicate that EGF receptors are consistently expressed by breast cells grown attached to a surface but that some cell lines expressing EGF receptors do not respond mitogenically to EGF. The biochemical characteristics of EGF receptors in MDA-MD-231 breast cells are similar to those observed for EGF receptors in other human tissues.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331647

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  43 in total

Review 1.  The role of endocytic Rab GTPases in regulation of growth factor signaling and the migration and invasion of tumor cells.

Authors:  N Porther; M A Barbieri
Journal:  Small GTPases       Date:  2015-08-20

Review 2.  The ErbB receptors as targets for breast cancer therapy.

Authors:  J Albanell; J Baselga
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-10       Impact factor: 2.673

3.  EGF binding is quantitatively related to growth in node-positive breast cancer.

Authors:  E Spitzer; K Koepke; D Kunde; R Grosse
Journal:  Breast Cancer Res Treat       Date:  1988-09       Impact factor: 4.872

4.  Epidermal growth factor receptor expression, proliferation, and colony stimulating activity production in the urinary bladder carcinoma cell line 5637.

Authors:  M Häder; D Stach-Machado; K H Pflüger; M Rotsch; B Heimann; K Moelling; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

5.  The EGF/CSF-1 paracrine invasion loop can be triggered by heregulin beta1 and CXCL12.

Authors:  Lorena Hernandez; Tatiana Smirnova; Dmitriy Kedrin; Jeffrey Wyckoff; Liyin Zhu; E Richard Stanley; Dianne Cox; William J Muller; Jeffrey W Pollard; Nico Van Rooijen; Jeffrey E Segall
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

6.  Correlation between epidermal growth factor receptor concentration and the growth of human gastric cancer xenografts in nude mice.

Authors:  T Kiyama; M Onda; A Tokunaga; I Fujita; T Okuda; T Mizutani; T Yoshiyuki; Y Shimizu; K Nishi; N Matsukura
Journal:  Gastroenterol Jpn       Date:  1992-08

7.  Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells.

Authors:  Brian D Adams; Kevin P Claffey; Bruce A White
Journal:  Endocrinology       Date:  2008-09-11       Impact factor: 4.736

8.  Epidermal growth factor receptor in breast cancer: correlation of quantitative immunocytochemical assays to prognostic factors.

Authors:  C Charpin; B Devictor; P Bonnier; L Andrac; M N Lavaut; C Allasia; L Piana
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

9.  Epidermal growth factor receptor and lipid membrane components in human lung cancers.

Authors:  A Di Carlo; A Mariano; P E Macchia; C Cecere; G Ferrante; V Macchia
Journal:  J Endocrinol Invest       Date:  1993-02       Impact factor: 4.256

10.  Prognostic value of epidermal growth factor receptor expression in cervical carcinoma.

Authors:  R J Hale; C H Buckley; W J Gullick; H Fox; J Williams; F L Wilcox
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.